This website is intended for healthcare professionals only.

Hospital Pharmacy Europe     Newsletter          

Oncology

European Commission approves Vyxeos to treat certain types of high-risk acute myeloid leukaemia
European Commission approves Vyxeos to treat certain types of high-risk acute myeloid leukaemia
Read more
NGS is helping oncologists make informed treatment decisions
NGS is helping oncologists make informed treatment decisions
Read more
New patient groups with cancer-associated VTE could be treated with once-daily oral LIXIANA, analysis shows
New patient groups with cancer-associated VTE could be treated with once-daily oral LIXIANA, analysis shows
Read more
CHMP gives positive opinion on using tisagenlecleucel to treat two aggressive blood cancers
CHMP gives positive opinion on using tisagenlecleucel to treat two aggressive blood cancers
Read more
Drug trial to investigate anti-tumour effect on patients with metastatic breast cancer
Drug trial to investigate anti-tumour effect on patients with metastatic breast cancer
Read more
Cancer in the UK elderly to almost double by 2035
Cancer in the UK elderly to almost double by 2035
Read more
Researchers show combination therapy can enhance ipilimumab immunotherapy
Researchers show combination therapy can enhance ipilimumab immunotherapy
Read more
EC approves adding overall survival data to Blincyto label
EC approves adding overall survival data to Blincyto label
Read more
Taking aspirin could help prevent bowel cancer
Taking aspirin could help prevent bowel cancer
Read more
Prostate cancer saliva test to start trials
Prostate cancer saliva test to start trials
Read more
Cancer Research UK tests first of its kind vaccine to treat lung cancer
Cancer Research UK tests first of its kind vaccine to treat lung cancer
Read more
NICE draft guidance rejects first-line use of Cabometyx
NICE draft guidance rejects first-line use of Cabometyx
Read more
Tesaro announces addition of Zejula to cancer drugs fund in UK
Tesaro announces addition of Zejula to cancer drugs fund in UK
Read more
Tiny particles could help fight brain cancer
Tiny particles could help fight brain cancer
Read more
Janssen stops Darzalex/Tecentriq combo trial
Janssen stops Darzalex/Tecentriq combo trial
Read more
NICE approves new advanced bladder cancer immunotherapy
NICE approves new advanced bladder cancer immunotherapy
Read more
Enhanced recovery programme enables patients to return home three days after major surgery
Enhanced recovery programme enables patients to return home three days after major surgery
Read more

Popular articles

Are anti-diabetic drugs the silver bullet for the obesity epidemic?
Use of colchicine associated with reduced risk of hip and knee replacement
Diagnostic spirometry for COPD on the rise





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora